JAMA Dermatology

Oncology & Cancer

Patients with rare skin cancer face 40% recurrence rate

Patients treated for Merkel cell carcinoma (MCC) face a five-year recurrence rate of 40%—markedly higher than the recurrence rates for melanoma and other skin cancers, according to research published today in JAMA Dermatology.

Oncology & Cancer

Study of patients with melanoma finds most have few moles

Most patients with melanoma had few moles and no atypical moles, and in patients younger than 60, thick melanomas were more commonly found in those with fewer moles but more atypical moles, according to an article published ...

Diseases, Conditions, Syndromes

For vitiligo patient, arthritis drug restores skin color

A medication for treating rheumatoid arthritis has restored skin color in a patient suffering from vitiligo, according to dermatologists at Yale School of Medicine. The disfiguring condition is best known as the disease that ...

Health

The bald facts on how best to fight hair loss in men

Nearly all men see their hairline recede or a bald spot emerge at some point in their life. For those looking to slow the march of time, a new study helps sort out which hair-loss medications work best.

page 3 from 37